The widow of a lawyer who took his own life, allegedly after taking the generic equivalent of widely prescribed antidepressant drug, Paxil, will not get a chance to undo a federal appeals court’s decision to toss out a federal jury’s findings that GSK, the maker of Paxil, owes her $3 million because it allegedly didn’t push federal regulators hard enough to revise the drug’s warning label.
Recent News About King & Spalding LLP View More
SCOTUS weighs competing briefs in widow's appeal in case vs GSK over suicide of lawyer taking generic Paxil
The U.S. Supreme Court is tackling the question of whether drug companies can be sued for not making their warning labels strong enough, even though the FDA controls the labels. But whether a forthcoming Supreme Court decision will affect a decision denying a $3 million judgment to the widow of a Chicago lawyer who committed suicide after taking the generic equivalent of Paxil remains unclear.
Judge: Enough proof big hotel brands manipulated online search results to let antitrust class action continue
A federal judge has turned down a bid by the world’s largest hotel brands, inlcuding Hilton, Hyatt and Wyndham, to shut the door on an antitrust class action accusing them of conspiring to boost room rates by working together to make it harder for consumers to compare prices online.